Cellectar Biosciences, Inc. Preferred Stock, Value, Issued
Cellectar Biosciences, Inc. (CLRB) had Preferred Stock, Value, Issued of $520.78 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-08-13
- 2026-03-31: Preferred Stock, Value, Issued $520.78K.
- 2025-12-31: Preferred Stock, Value, Issued $520.78K.
- 2025-09-30: Preferred Stock, Value, Issued $520.78K.
- 2025-06-30: Preferred Stock, Value, Issued $520.78K.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2026-03-31 | $520.78K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $520.78K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $520.78K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $520.78K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $520.78K 10-Q · filed 2025-11-13 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.38M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.38M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.38M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $1.38M 10-Q · filed 2022-11-03 |
| 2021-12-31 | $1.38M 10-K · filed 2023-03-09 |
| 2020-09-30 | $1.15M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.15M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $1.15M 10-Q · filed 2020-11-09 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-10 |
| 2018-03-31 | $637.02K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $995.78K 10-Q · filed 2018-08-10 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 |
| 2016-12-31 | $875.57K 10-Q · filed 2017-11-09 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-20 |
| 2014-12-31 | $0.00 10-K/A · filed 2016-10-20 |
| 2014-09-30 | $0.00 10-Q · filed 2015-05-20 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-04 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 |
| 2013-12-31 | $0.00 10-Q · filed 2015-05-20 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-12 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-19 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-06 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |